Xiaoxiang Rong

Xiaoxiang Rong

UNVERIFIED PROFILE

Are you Xiaoxiang Rong?   Register this Author

Register author
Xiaoxiang Rong

Xiaoxiang Rong

Publications by authors named "Xiaoxiang Rong"

Are you Xiaoxiang Rong?   Register this Author

8Publications

159Reads

11Profile Views

miR-577 Regulates TGF-β Induced Cancer Progression through a SDPR-Modulated Positive-Feedback Loop with ERK-NF-κB in Gastric Cancer.

Mol Ther 2019 Jun 10;27(6):1166-1182. Epub 2019 Feb 10.

Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymthe.2019.02.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554531PMC
June 2019

Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I-III colon cancer.

Cancer Immunol Immunother 2019 Mar 19;68(3):433-442. Epub 2018 Dec 19.

Department of Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, People's Republic of China.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-018-2289-7
Publisher Site
http://dx.doi.org/10.1007/s00262-018-2289-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426802PMC
March 2019

MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer.

Mol Cancer 2017 07 17;16(1):122. Epub 2017 Jul 17.

Cancer Center, Traditional Chinese Medicine-Integrated Hospital, Southern medical University, Guangdong, 510315, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12943-017-0698-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514511PMC
July 2017

Targeted Disruption of miR-17-92 Impairs Mouse Spermatogenesis by Activating mTOR Signaling Pathway.

Medicine (Baltimore) 2016 Feb;95(7):e2713

From the Cancer Research Institute, Southern Medical University (RX, XL, HS, FW, WH, TL, XL, YQ, HW, LC, SY, JY, KY, DX, JJ); Institute of Comparative Medicine and Laboratory Animal Center, Southern Medical University (RX, DX); Zhongshan School of Medicine, Sun Yat-sen University (YS); Department of Endocrinology, The Second Affiliated Hospital, Guangzhou Medical University (TD); Department of General Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou (KX); Department of Chemoradiotherapy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou (RX); Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University (KX); Department of Oncology, Nanfang Hospital, Southern Medical University (XR); and Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China (FW).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000002713DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998608PMC
February 2016

The Association Between Body Mass Index and the Prognosis and Postoperative Complications of Hepatocellular Carcinoma: A Meta-Analysis.

Medicine (Baltimore) 2015 Aug;94(31):e1269

From the Department of Oncology, Nanfang Hospital (XR); Department of Oncology, Traditional Chinese Medicine-Integrated Hospital (XR, QG, JR, AL, RL); Cancer Research Institute, Southern Medical University, Guangzhou (FW, HS); Department of Oncology, Changzhou No.2 People's Hospital, The Affiliated Hospital of Nanjing Medical University, Changzhou (QG); and Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province, China (FW).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000001269DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616596PMC
August 2015

Effective activity of cytokine induced killer cells against hepatocellular carcinoma including tumor-initiating cells.

Med Hypotheses 2015 Mar 27;84(3):159-61. Epub 2014 Aug 27.

Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong Province, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mehy.2014.08.022DOI Listing
March 2015

MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma.

Carcinogenesis 2014 Dec 3;35(12):2748-55. Epub 2014 Oct 3.

Department of Clinical examination, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510260, People's Republic of China

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgu208DOI Listing
December 2014

Positron emission tomography-computed tomography on predicting the efficacy of targeted therapy for lung adenocarcinoma.

Thorac Cancer 2014 Jul 3;5(4):297-303. Epub 2014 Jul 3.

Department of Oncology, Nanfang Hospital, Southern Medical University Guangzhou, Guangdong Province, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1759-7714.12092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704353PMC
July 2014